Hypolipidaemic drugs and nonalcoholic fatty liver disease (NAFLD): a case report

被引：0
|
作者：
Tsesmeli, N. [1 ]
Savopoulos, C. [1 ]
Sidiropoulos, I. [1 ]
Hitiroglou, P. [2 ]
Kaiafa, G. [1 ]
Koliouskas, D. [1 ]
机构：
[1] AHEPA Hosp, Med Propedeut Dept 1, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Dept Pathol, GR-54006 Thessaloniki, Greece
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2004年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [11] Intestinal permeability in nonalcoholic fatty liver disease (NAFLD).
    Miele, L
    Valenza, V
    Mascianà, R
    Gabrieli, ML
    Perotti, G
    Cammarota, G
    Montalto, M
    Forgione, A
    Vero, V
    Gasbarrini, G
    Grieco, A
    HEPATOLOGY, 2004, 40 (04) : 585A - 585A
  • [12] CHARACTERISTICS OF THE FATTY ACID COMPOSITION IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Yamada, K.
    Mizukoshi, E.
    Takeshita, Y.
    Arai, K.
    Yamashita, T.
    Sakai, A.
    Kaneko, S.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S505 - S506
  • [13] The clinical and pathological spectrum of nonalcoholic fatty liver liver disease (NAFLD)
    Copaci, I
    Voiculescu, M
    Micu, L
    Hortopan, M
    Cojocaru, L
    JOURNAL OF HEPATOLOGY, 2002, 36 : 255 - 255
  • [14] VASCULAR FUNCTION CHANGES IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)/ NONALCOHOLIC STEATOHEPATITIS
    Jafari, Kaveh
    Paquet, Veronique
    Addour, Saliha
    Fortie, Catherine
    Trepan, Gabrielle
    Ferlan, Stephanie
    Agharazii, Mohsen
    Carre, Anne-Marie
    JOURNAL OF HYPERTENSION, 2024, 42
  • [15] Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH)
    Ota, Tsuguhito
    CAROTENOIDS: BIOSYNTHETIC AND BIOFUNCTIONAL APPROACHES, 2021, 1261 : 223 - 229
  • [16] A Lipidomic Readout of Disease Progression in Nonalcoholic Fatty Liver Disease (NAFLD)
    Pacana, Tommy
    Min, Hae K.
    Patel, Vaishali
    Katainen, Riikka
    Vihervaara, Terhi
    Mirshahi, Faridoddin
    Puri, Puneet
    Sanyal, Arun J.
    HEPATOLOGY, 2013, 58 : 531A - 531A
  • [17] Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
    Kaswala, Dharmesh H.
    Lai, Michelle
    Afdhal, Nezam H.
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (05) : 1356 - 1364
  • [18] Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD)
    Xin, Xin
    Chen, Cheng
    Hu, Yi-Yang
    Feng, Qin
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
  • [19] Nonalcoholic fatty liver disease (NAFLD): Approach in the adolescent patient
    Roberts E.A.
    Yap J.
    Current Treatment Options in Gastroenterology, 2006, 9 (5) : 423 - 431
  • [20] Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
    Ajay Duseja
    Naga Chalasani
    Hepatology International, 2013, 7 : 755 - 764
12345